Article
Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer
21 Jan 2025
Abstract excerpt
BACKGROUND: A new circulating biomarker superior to carbohydrate antigen 19-9 (CA19-9) is needed for diagnosing pancreatobiliary cancer (PBca). The aim of this study was to identify serum microRNA (miRNA) signatures comprising reproducible and disease-related miRNAs. METHODS: This multicenter study involved patients with treatment-naïve PBca and healthy participants. The optimized serum processing conditions were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
